Estalis 50/140
Estalis 50/140 is a medicine authorised by Swissmedic under authorisation number 54704. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 17 August 1999 and the authorisation is valid without a time limit. ATC code G03FA01 places the medicine in the group Sex hormones and modulators of the genital system.
| Authorisation number | 54704 |
|---|---|
| Name | Estalis 50/140 |
| Full name | Estalis 50/140, transdermale Pflaster |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | G03FA01 |
| First authorisation | 17 August 1999 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Estalis 50/140, transdermale Pflaster | B | 17 August 1999 |
| 2 | Estalis 50/250, transdermale Pflaster | B | 17 August 1999 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 62 | 8 | Pflaster | G03FA01 | 07.08.6. | B |
| 70 | 24 | Pflaster | G03FA01 | 07.08.6. | B |
| 89 | 8 | Pflaster | G03FA01 | 07.08.6. | B |
| 97 | 24 | Pflaster | G03FA01 | 07.08.6. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Estalis 50/140 authorised in Switzerland?
Yes. Estalis 50/140 is authorised by Swissmedic under authorisation number 54704, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Estalis 50/140 have?
Estalis 50/140 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Estalis 50/140?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.